7/23/2010

Impax Laboratories received FDA approval for a 30-milligram dose of generic Opana ER, an extended-release pain tablet by Endo Pharmaceuticals Holdings and Penwest Pharmaceuticals. The approval entitles Impax to 180 days of market exclusivity.

Related Summaries